KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study

Autor: Simone Ferrero, Davide Rossi, Andrea Rinaldi, Alessio Bruscaggin, Valeria Spina, Christian W. Eskelund, Andrea Evangelista, Riccardo Moia, Ivo Kwee, Christina Dahl, Alice Di Rocco, Vittorio Stefoni, Fary Diop, Chiara Favini, Paola Ghione, Abdurraouf Mokhtar Mahmoud, Mattia Schipani, Arne Kolstad, Daniela Barbero, Domenico Novero, Marco Paulli, Alberto Zamò, Mats Jerkeman, Maria Gomes da Silva, Armando Santoro, Annalia Molinari, Andres Ferreri, Kirsten Grønbæk, Andrea Piccin, Sergio Cortelazzo, Francesco Bertoni, Marco Ladetto, Gianluca Gaidano

Publikováno v: Haematologica, Vol 105, Iss 6 (2020)

In recent years, the outcome of mantle cell lymphoma (MCL) has improved, especially in younger patients, receiving cytarabine-containing chemoimmunotherapy and autologous stem cell transplantation. Nevertheless, a proportion of MCL patients still exp

Externí odkaz: https://doaj.org/article/a42fa36371644826a93ee7901afe5a7c

Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study

Autor: Umberto Vitolo, Annalisa Chiappella, Emanuele Angelucci, Giuseppe Rossi, Anna Marina Liberati, Maria Giuseppina Cabras, Barbara Botto, Giovannino Ciccone, Gianluca Gaidano, Lorenzo Falchi, Roberto Freilone, Domenico Novero, Lorella Orsucci, Vincenzo Pavone, Enrico Pogliani, Delia Rota-Scalabrini, Flavia Salvi, Anna Tonso, Alessandra Tucci, Alessandro Levis

Publikováno v: Haematologica, Vol 94, Iss 9 (2009)

Background We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma.Design and Methods Ninety-four young patie

Externí odkaz: https://doaj.org/article/e95f5885ff664ac9be3329bb97c79b2a

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy:a FIL study

Autor: Abdurraouf Mokhtar Mahmoud, Chiara Favini, Kirsten Grønbæk, Domenico Novero, Armando Santoro, Davide Rossi, Arne Kolstad, Andrea Rinaldi, Andrés J.M. Ferreri, Valeria Spina, Christian Winther Eskelund, Simone Ferrero, Paola Ghione, Daniela Barbero, Sergio Cortelazzo, Andrea Evangelista, Marco Ladetto, Vittorio Stefoni, Mattia Schipani, Alice Di Rocco, Fary Diop, Mats Jerkeman, Riccardo Moia, Francesco Bertoni, A. L. Molinari, Andrea Piccin, Gianluca Gaidano, Alberto Zamo, Christina Dahl, Alessio Bruscaggin, Marco Paulli, Ivo Kwee, Maria Gomes da Silva

Publikováno v: Ferrero, S, Rossi, D, Rinaldi, A, Bruscaggin, A, Spina, V, Eskelund, C W, Evangelista, A, Moia, R, Kwee, I, Dahl, C, Di Rocco, A, Stefoni, V, Diop, F, Favini, C, Ghione, P, Mahmoud, A M, Schipani, M, Kolstad, A, Barbero, D, Novero, D, Paulli, M, Zamò, A, Jerkeman, M, Gomez Da Silva, M, Santoro, A, Molinari, A, Ferreri, A, Grønbæk, K, Piccin, A, Cortelazzo, S, Bertoni, F, Ladetto, M & Gaidano, G 2020, ' KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy : a FIL study ', Haematologica, vol. 105, no. 6, pp. 1604-1612 . https://doi.org/10.3324/haematol.2018.214056
Haematologica

In recent years, the outcome of mantle cell lymphoma (MCL) has improved, especially in younger patients, receiving cytarabine-containing chemoimmunotherapy and autologous stem cell transplantation. Nevertheless, a proportion of MCL patients still exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71bb4bed69ead5fc1ced7539a5c7f058
https://curis.ku.dk/portal/da/publications/kmt2d-mutations-and-tp53-disruptions-are-poor-prognostic-biomarkers-in-mantle-cell-lymphoma-receiving-highdose-therapy(f78720d5-b8ac-4f69-b123-a83649e8457d).html

A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era. Selecting cases, matching clinical benefit. A position paper from the Italian Group of Haematopathology (G.I.E.)

Autor: Maurilio Ponzoni, Fabio Facchetti, Claudio Tripodo, Maria Raffaella Ambrosio, Alberto Zamo, Stefano Lazzi, Arianna Di Napoli, Domenico Novero, Marco Lucioni, Marco Paulli, Claudio Agostinelli, Elena Sabattini, Alessia Carbone, Stefano Ascani, Stefano Pileri, Luigi Ruco, Lorenzo Leoncini, D. Remotti

Publikováno v: Virchows Archiv

An accurate diagnosis of clinically distinct subgroups of aggressive mature B cell lymphomas is crucial for the choice of proper treatment. Presently, precise recognition of these disorders relies on the combination of morphological, immunophenotypic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::975d6cfdc66a794fa72288585a109827
http://hdl.handle.net/11573/1310046

Minimally invasive, ionizing-free, and ultrasound-guided technique to biopsy anterior mediastinal masses: First 60 cases

Autor: Riccardo Carlo Cristofori, Elio Rolfo, Enrico Ruffini, Bruno Tartaglino, Bartolomeo Lorenzati, Domenico Novero, Andrea Landi, Giuseppe Lauria, Luca Scaglione, Alberto Oliaro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bcac6a6c6acb8459e44da12a6be53a7
http://hdl.handle.net/2318/1679151